Replies to post #19478 on Intellipharmaceutics International Inc. (IPCI)

[fabius]

Here is something strange (or funny);

I think everything Zacks was reportedly writing is in someway inaccurate, except the 2 generics ANDA, which makes no sense.

According to Zacks Investment Research, “Intellipharmaceutics International Inc. is engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. Its products include Effexor XR and Protonix. The Company offers products in different stages of development in therapeutic areas, including neurology, cardiovascular, and GIT. Intellipharmaceutics International Inc. was formerly known as IntelliPharmaCeutics Ltd. and is based in Toronto, Canada.”

I mean...why citing 2 ANDA still pending and no mention of the other catalyst and/or approval/partnership

[AngeloFoca]

upgraded by Zacks Investment Research from a “sell” rating to a “buy” rating

You can make a small fortune following their advice... all you need, is to start out with a large fortune.

So it's a sell at $2.00 and buy at $3.00 - must be the friend sprot refers to for advice.